Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Vascular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001346
What this trial is testing

Diabetic Retinopathy and Visual Function Study

Who this might be right for
Diabetic RetinopathyMacular DegenerationVision, Subnormal
National Eye Institute (NEI) 100
Not applicableStudy completedNCT02853747
What this trial is testing

Exercise and Arterial Modulation in Youth

Who this might be right for
Cardiovascular DiseaseChildhood ObesityHypertension+1 more
University of Basel 337
Testing effectiveness (Phase 2)Looking for participantsNCT03161652
What this trial is testing

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaDiabetic Retinopathy
Carmen Clapp 120
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Large-scale testing (Phase 3)Study completedNCT06305416
What this trial is testing

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaDiabetic RetinopathyMacular Edema+3 more
Incepta Pharmaceuticals Ltd 70
Large-scale testing (Phase 3)Ended earlyNCT03802630
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 450
Not applicableNot Yet RecruitingNCT06918028
What this trial is testing

An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

Who this might be right for
Retinal DiseasesChoroidal DiseasePathological Myopia+3 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 9,999
Testing effectiveness (Phase 2)UnknownNCT02486484
What this trial is testing

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Who this might be right for
NeovascularizationMacular DegenerationDiabetic Retinopathy+5 more
Rafic Hariri University Hospital 100
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Testing effectiveness (Phase 2)Study completedNCT01205035
What this trial is testing

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia

Who this might be right for
Retinal DiseasesTelangiectasis
Eye Center of Northern Colorado, P.C. 6
Early research (Phase 1)Study completedNCT00463320
What this trial is testing

Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.

Who this might be right for
Macular DegenerationAge-related Macular Degeneration
GlaxoSmithKline 29
Large-scale testing (Phase 3)Ended earlyNCT04611152
What this trial is testing

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 460
Not applicableUnknownNCT03823092
What this trial is testing

Polarization Perception in Health and Disease. Testing a New Sight Test

Who this might be right for
CataractAge Related Macular DegenerationPseudophakia+3 more
South Warwickshire NHS Foundation Trust 300
Large-scale testing (Phase 3)Study completedNCT02376075
What this trial is testing

Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria

Who this might be right for
Arterial HypertensionAlbuminuria
ikfe-CRO GmbH 43
Not applicableEnrolling By InvitationNCT06583395
What this trial is testing

Quest to Analyze One Thousand Humans Meditating

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Angina, StableAnxiety+52 more
Tobias Moeller-Bertram 3,000
Not applicableLooking for participantsNCT06500728
What this trial is testing

Visual Involvement in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisVisual ImpairmentCentral Retinal Artery Occlusion+6 more
ASST Fatebenefratelli Sacco 762
Large-scale testing (Phase 3)Study completedNCT00198497
What this trial is testing

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Who this might be right for
Vitreous HemorrhageDiabetic Retinopathy
Bausch & Lomb Incorporated 510
Large-scale testing (Phase 3)Ended earlyNCT05066230
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Non-proliferative Diabetic Retinopathy
Kodiak Sciences Inc 253
Not applicableLooking for participantsNCT03475173
What this trial is testing

New Non-invasive Modalities for Assessing Retinal Structure and Function

Who this might be right for
Ischemic Optic NeuropathyBranch Retinal Artery OcclusionHemianopia+2 more
Randy Kardon 500
Not applicableStudy completedNCT00001395
What this trial is testing

Long Term Follow-Up of Diabetic Retinopathy

Who this might be right for
BlindnessCataractDiabetes Mellitus+2 more
National Eye Institute (NEI) 75
Next Page